Vinblastine + Tolterodine Tartrate Interaction

Moderateinteraction on record

Description

CYP3A4 inhibitor that may increase tolterodine plasma concentrations. Dose reduction to 1 mg twice daily is recommended.

Mechanism

CYP3A4 inhibition

Source: NLP:tolterodine tartrate